Back
Adtalem Global Education, Inc. Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Buy
58
ATGE
Adtalem Global Education, Inc.
Last Price:
$103.52
Seasonality Move:
4.94%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$784.09
Seasonality Move:
12.13%
Buy
58
Adtalem Global Education, Inc. (ATGE)
is a Buy
Is Adtalem Global Education, Inc. a Buy, Sell or Hold?
-
The current Adtalem Global Education, Inc. [ATGE] share price is $103.66. The Score for ATGE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ATGE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $783.71. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATGE Stock Price Chart
What is Adtalem Global Education, Inc.'s stock price today?
-
The Adtalem Global Education, Inc. share price today is $103.66The current trend is relatively stagnant and ATGE is experiencing slight buying pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $783.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
ATGE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 58.46 | Buy |
| Chaikin Money Flow: | 50612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.78 - 99.8) | Buy |
| Bollinger Bands (100): | (100.12 - 145.72) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 204.17 | Buy |
| Relative Strength Index (14 RSI): | 67.2 | Buy |
| Chaikin Money Flow: | -261329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (720.67 - 774.53) | Buy |
| Bollinger Bands (100): | (555.56 - 709.04) | Buy |
ATGE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.01 | Buy |
| 20-day SMA: | 96.65 | Buy |
| 50-day SMA: | 108.83 | Sell |
| 200-day SMA: | 119.13 | Sell |
| 8-day EMA: | 100.88 | Buy |
| 20-day EMA: | 99.2 | Buy |
| 50-day EMA: | 106.67 | Sell |
| 200-day EMA: | 113.43 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 764.21 | Buy |
| 20-day SMA: | 747.28 | Buy |
| 50-day SMA: | 691.09 | Buy |
| 200-day SMA: | 601.8 | Buy |
| 8-day EMA: | 603.24 | Buy |
| 20-day EMA: | 348.3 | Buy |
| 50-day EMA: | 164.33 | Buy |
| 200-day EMA: | 44.8 | Buy |
Adtalem Global Education, Inc. Earnings Growth & ATGE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.61 per share, and an increase next year of $1.30 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Adtalem Global Education, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||